Linksys Announces the Next Step in Home and Small Office WiFi Mesh Optimization
Linksys®, an iconic Home and Small Office connectivity company, announces in a statement of direction its new “Cognitive Mesh” capability currently shipping in the Velop Pro 6E and in the coming months on the Velop Pro 7, Velop Micro Router 6, Velop Micro Mesh 6.
“Cognitive” in the technology space refers to “thinking technologies” that can deterministically, either by User selection or automation, solve problems. Linksys Cognitive Mesh in Phase 1 of its implementation, developed entirely based on User input and feedback, focuses on User selection for the following:
- Lightning-fast setup of a WiFi Multi-Mesh Node System (up to 3 Nodes completed in less than 10 minutes)*
- User selectable WiFi Mesh Network topology for their Home or Small Office (Mesh Node direct connection to Router or Mesh Node Daisy-Chain connection to Router)
- User selectable WiFi Mesh Network operating mode for their Home or Small Office (Collaboration, Streaming, Gaming, or Internet of Things (IoT))
Phase 1 of Linksys Cognitive Mesh will be completed by the end of this calendar year and is purpose-built for products using Qualcomm® Immersive Home and Qualcomm® Networking Pro Series platforms that can operate in 2.4 GHz, 5.0 GHz, and 6 GHz WiFi bands. Linksys Cognitive Mesh is not meant to interoperate with Linksys Intelligent Mesh and should not be co-mingled in the same Mesh Network. Phase 2 of Linksys Cognitive Mesh is currently under development and includes new patentable methods to reduce the cost of powering and operating a Whole Home WiFi Mesh System as well as automatic optimization of WiFi Mesh System operating modes.
“WiFi Mesh Systems are rapidly becoming mainstream for Home and Small Office Networks,” said Timothy Tsai – Director of Product Development at Linksys. “To engineer the simplicity needed for Mesh Networks to succeed the semi-static methods of the past had to be scrapped in favor of the near real-time Cognitive or thinking technologies that are re-defining the present and will define the future.”
About Linksys
“At Linksys, we engineer simplicity so that you never experience complexity.” Linksys is an iconic brand celebrating its 35th year of innovation in Home and Small Office connectivity. Linksys has many industry firsts to its credit and are proven experts at delivering simple, fast, reliable, and affordable products for the Home and Small Office where there is “No IT.”
© 2023 Linksys Holdings, Inc. and/or its affiliates. All rights reserved.
Linksys and many product names and logos are trademarks of Linksys Holdings Inc. and/or its affiliates. Third-party trademarks mentioned are the property of their respective owners.
Qualcomm is a trademark or registered trademark of Qualcomm Incorporated.
Qualcomm Immersive Home Platform and Qualcomm Networking Pro Series Platforms are products of Qualcomm Technologies, Inc. and/or its subsidiaries.
*Setup times may vary for your unique home network.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230920666407/en/
Contact information
Media Contact
comms@linksys.com
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Novotech Issues White Paper to Help Sponsors Strengthen Early-Phase Oncology Strategy and Execution15.12.2025 14:05:00 CET | Press Release
Novotech, a leading global full-service clinical research organization (CRO) and scientific advisory company, has released a new white paper, Early-Phase Oncology – Clinical Research Landscape and CRO Enablers (2025), offering in-depth analysis of the key drivers shaping early-phase oncology development. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251215843975/en/ With approximately 60% of oncology agents progressing from Phase I to Phase II, but only 3–6% reaching regulatory approval, the paper outlines the factors influencing early-stage success, including trial design, patient selection, and regional development pathways. The paper highlights Australia’s continued position as a global first-in-human (FIH) and early-phase research hub. Its ethics-led review frameworks, which can support trial initiation within roughly 4–8 weeks, combined with established FIH centers, oncology networks, and cost efficiencies, position Au
Ant Group Announces Major Upgrades to Its 15-Million-MAU AI Health App AQ Amid Wider Push into Health Sector15.12.2025 14:03:00 CET | Press Release
Ant Group today announced major upgrades to its AI health app AQ, with a new Chinese name “Ant A-Fu.” The character “Fu” conveys good wishes and well-being, reflecting the app’s goal to promote better health and quality of life. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251215203213/en/ Ant Group’s AI health app AQ features three core capabilities: health Q&A, AI health companion, and integrated health services. The upgraded version of AQ now features three core capabilities: health Q&A, AI health companion, and integrated health services. Launched in June 2025, AQ has rapidly grown to 15 million monthly active users, making it China’s leading AI health management app. Positioned as an AI health companion service, AQ currently answers over 5 million health-related questions every day. The announcement comes amid China’s ongoing demographic shift. According to projections from the National Health Commission, by around 20
Copeland and Daikin Cooperation Brings Solutions to European Customers15.12.2025 14:00:00 CET | Press Release
Copeland and Daikin, two global leaders in heating, ventilation and air conditioning (HVAC) solutions, today announced the expansion of their existing joint venture into Europe. Through this cooperation, the companies will introduce advanced inverter swing rotary compressors, power electronics and controls designed specifically for European residential heat pumps. This collaboration underscores both companies’ commitment to accelerate the energy transition, with heat pumps recognized by industry reports as a cornerstone technology helping to reduce global carbon dioxide emissions by an estimated 500 million tons by 2030. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251215625806/en/ (Left to right) Ross B. Shuster, CEO of Copeland and Jiro Tomita, executive associate officer of Daikin As Europe rapidly transitions away from fossil fuels, the demand for residential heat pumps is growing in parallel with ambitious sustainabil
Visa Unveils New Global Stablecoins Advisory Practice15.12.2025 13:00:00 CET | Press Release
Visa (NYSE: V), a global leader in digital payments, today announced the launch of its Stablecoins Advisory Practice. The new value-added service offering by Visa Consulting & Analytics (VCA) provides actionable insights and recommendations to guide banks, fintechs, merchants, and businesses of all sizes on market fit, strategy, and implementation. As the stablecoin market cap surpasses $250 billion, Visa’s settlement volume has accelerated, reaching a $3.5 billion annualized run rate as of November 30. Businesses are turning to Visa’s new Stablecoins Advisory Practice to unlock growth opportunities. “Putting our members first has always been our mission, and we’re committed to exploring innovations that strengthen financial health and convenience for those we serve. Stablecoins may represent an opportunity to enhance speed and lower cost in payments, so with the support of Visa, we are evaluating how this technology could fit into our broader strategy to deliver meaningful value to ou
SK Capital Announces Definitive Agreement to Invest in Swixx BioPharma AG to Drive the Next Phase of Growth and Global Expansion15.12.2025 12:30:00 CET | Press Release
SK Capital Partners, LP (“SK Capital”), a New York-based private investment firm focused on the life sciences, specialty materials, and ingredients sectors, today announced that its affiliate has reached an agreement to invest in Swixx BioPharma AG (“Swixx” or the “Company”) to accelerate the Company’s next phase of growth and global expansion. The investment values the Company in excess of EUR €1.5 billion. Swixx is the global leader in rest-of-world pharmaceutical commercialization services dedicated to delivering innovative, life-saving medications to underserved and hard-to-reach markets. Stuart Swanson and Petr Němec, Swixx’s Co-Founders, and Jean-Michel Lespinasse and Petr Pipal, Swixx’s CEO and CFO, respectively, will all retain significant ownership stakes in Swixx as part of the transaction. Existing institutional investors HBM Healthcare Investments, a Swiss-listed investment company for the global healthcare market, and Mérieux Equity Partners, a leading healthcare-specializ
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom